Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Alumis Inc. (ALMS) Financial Statements

Alumis Inc. (ALMS) reported trailing twelve-month revenue of $7.4M (up 288.7% year on year) and net income of -$439.0M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$351.8M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ALMSAlumis Inc.Follow ALMS — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
877.6M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
12 Nov, in 19 days

Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.

LineFY2025
Dec 25
TTM
Jun 26
Trend
Revenue24.17.4
Research & development386.0347.5
Operating income-453.8-459.0
Pre-tax income-251.9-440.7
Income tax-8.6-1.8
Net income-243.3-439.0
Diluted EPS ($)-2.86-3.42
Diluted shares (mn)85.0—

USD millions · SEC XBRL

Alumis Inc. — questions

What is Alumis Inc.'s revenue?
$7.4M over the twelve months to 2026-06-30, up 288.7% year on year, from its 10-Q and 10-K filings.
What is Alumis Inc.'s net income?
-$439.0M over the twelve months to 2026-06-30.
What is Alumis Inc.'s free cash flow?
-$351.8M over the twelve months to 2026-06-30.
What are Alumis Inc.'s diluted earnings per share?
$-3.42 over the twelve months to 2026-06-30.

Every figure on this page comes from Alumis Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.